Nizatidine

CAS 76963-41-2 2 current records 3 historicalSmall Molecule

Who holds supplier records for Nizatidine? 2 organisations hold a current record for Nizatidine: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (2).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Nizatidine: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nizatidine

Reading the evidence

  • 2 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    2 of the 2 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (2)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Nizatidine. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Nizatidine sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Nizatidine, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
SOLARA ACTIVE PHARMA SCIENCES LIMITED ChennaiIN
CEP 2000-083 - Rev 10
Nizatidine
Dec 2023—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
R1-CEP 2002-027 - Rev 06
Nizatidine
Apr 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Nizatidine are no longer active. These show a past filing, not current supply.

Show all 3 historical records
  • Italy · Inactive DMF 18545 · filed Jul 2005
  • India · Inactive DMF 14710 · filed Feb 2000
  • EURO CHEMI INC
    Inactive DMF 14101 · filed Apr 1999

Overview

Nizatidine is a histamine H2 receptor antagonist that inhibits stomach acid production. It is used in the treatment of peptic ulcer disease and gastroesophageal reflux disease (GERD).

Chemical identity

IUPAC name
1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
Canonical SMILES
CNC(=C[N+](=O)[O-])NCCSCC1=CSC(=N1)CN(C)C
InChIKey
SGXXNSQHWDMGGP-UHFFFAOYSA-N
Synonyms
Axid API, acinon, axid, axid ar, ly 139037, nsc-759289

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Histamine-2 Receptor Antagonist
Mechanism of action
Histamine H2 Receptor Antagonists

Therapeutic areas

Gastroenterology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Nizatidine?

2 organisations hold an active US FDA Type II Drug Master File or a CEP for Nizatidine: Dr. Reddy's Laboratories Ltd. (India) and SOLARA ACTIVE PHARMA SCIENCES LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Nizatidine Drug Master Files are active?

Dr. Reddy's Laboratories Ltd. (DMF 14036) and SOLARA ACTIVE PHARMA SCIENCES LTD (DMF 13192). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Nizatidine records mean?

3 organisations have only inactive Type II DMFs for Nizatidine. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Nizatidine have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Nizatidine on the EDQM register, including SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai (IN) and DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Nizatidine supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Nizatidine?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.